| |
|
|
|
Emmaus Life Sciences Inc.  
|
|
1.41 0 (0%) |
02-26 15:48 |
|
Open: |
1.41 |
Pre close: |
1.41 |
Target:
|
1.90
|
|
High: |
1.43 |
Low: |
1.4 |
Resistance:
|
1.63
1.89
|
|
Volume: |
2,182 |
Market Cap: |
69M |
Support:
|
1.20
1.00
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.49
 |
MACD |
MACD(12,26):
|
0.04 |
|
MA(20): |
1.57  |
Signal(12,26,9): |
0.09 |
|
MA(100): |
1.15 |
Stochastic Oscillator |
%K(14,3):
|
18.55 |
|
MA(250): |
1.37 |
%D(3): |
31.87 |
|
Average Volume(K) |
3-Month: |
2216
|
52-Week |
High:
|
2.16 |
|
10-Days: |
1882 |
Low: |
0.70 |
|
RSI |
RSI(14):
|
44.97 |
Change(%): |
-6.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.089 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
48.99 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-2.0 |
Shares Float (M) |
29.50 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
21.69 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
24.6 |
% Held by Institutions |
0.09 |
|
Forward EPS |
-1.650 |
Gross Profit (p.s.) |
0.442 |
Shares Short (K) |
41 |
|
Book Value (p.s.) |
-0.370 |
EBITDA (p.s.) |
-0.042 |
P/E |
-0.67 |
|
Sales Per Share |
0.464 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-3.81 |
|
Profit Margin |
-241.04 |
Operating Cash Flow
(M) |
-4.52 |
P/S |
3.04 |
|
Operating Margin |
-9.28 |
Levered Free Cash Flow
(M) |
-0.40 |
P/CF |
-15.28 |
|
|
|
|
|
|
